Close Menu

NEW YORK (GenomeWeb) – CombiMatrix is facing a delisting of its stock from the Nasdaq for failing to meet the stock exchange's $1 minimum bid price, the molecular diagnostics firm disclosed last week in a filing with the US Securities and Exchange Commission.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Three genetic testing companies form a coalition to influence how Congress considers genetic privacy, The Hill reports.

University of California, San Diego researchers investigate how skin care products influence the skin microbiome, Scientific American reports.

The Wall Street Journal examines billing codes used by uBiome.

In PNAS this week: links between lung adenocarcinoma and lncRNA, algorithm to impute and cluster Hi-C interaction profiles from single cells, and more.